SWCS urges Biotech companies to make proper disclosures

HKEX (00388) has updated Hong Kong’s listing rules to allow non-profitable biotech companies to list. SWCS, the company secretarial service provider for Ascletis Pharma Inc, reminded biotech companies to strike a balance between complying with required disclosures and protecting their intellectual properties.


This article is available in Chinese only.